<DOC>
	<DOCNO>NCT01014819</DOCNO>
	<brief_summary>The Dermacorder measure electric field skin . Malignant skin lesion disrupt skin 's normal electric field abnormal electric field detect Dermacorder . Therefore investigator test hypothesis Dermacorder provide useful data guide diagnosis skin disease .</brief_summary>
	<brief_title>A Clinical Trial Dermacorder Detecting Malignant Skin Lesions</brief_title>
	<detailed_description>The Dermacorder non-invasive medical device scan probe skin 200 micron away detect electric field skin use capacitative coupling . Measurements hundred malignant melanomas mouse indicate lesion generate electric field easily detect . One previous clinical trial VA Medical Center Hampton VA indicate 80 % reliability predict malignant lesion electric field . We improve Dermacorder past two year enhance sensitivity stability must determine improvement improve ability detect malignant lesion . If Dermacorder provide reliable diagnosis malignant lesion , use could dramatically reduce number biopsy perform would significantly improve quality life hundred thousand Americans seek advice dermatologist regard suspicious lesion year</detailed_description>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<criteria>Study subject must diagnose least one benign malignant skin lesion ; Subject 1875 year age , inclusive ; Subject must sign date inform consent statement . Subject exhibit sign bacterial viral infection , include fever ; Subject unwilling allow biopsy malignant lesion histological analysis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Dermacorder</keyword>
	<keyword>Electric field</keyword>
	<keyword>basal cell carcinoma</keyword>
	<keyword>Gorlin Syndrome</keyword>
</DOC>